QR code

One year follow up of phase 1/2 randomized, placebo controlled trial of NDV-HXP-S vaccine in Thailand

Abstract To promote self-reliance in vaccine production, a chimeric Newcastle Disease Virus (NDV) based vaccine (NDV-HXP-S) was developed in Bangkok, Thailand, with the support of PATH. The interim results of phase 1 on initial safety and immune responses of five formulations: 1 µg, 3 µg, 10 µg, 1 µ...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Weerapong Phumratanaprapin, Viravarn Luvira, Saranath Lawpoolsri, Juthaporn Cowan, Sant Muangnoicharoen, Supitcha Kamolratanakul, Yupa Sabmee, Piengthong Narakorn, Somchaiya Surichan, Laina D. Mercer, Rama Raghunandan, Christina S. Polyak, Ponthip Wirachwong, Jorge Flores, Bruce L. Innis, Punnee Pitisuttithum
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Portfolio 2025-11-01
Reeks:npj Vaccines
Online toegang:https://doi.org/10.1038/s41541-025-01321-8
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items